Pharma Deals Review, Vol 2006, No 71 (2006)

Font Size:  Small  Medium  Large

GlaxoSmithKline and Sirna Enter Major RNAi Collaboration

Business Review Editor

Abstract


Global giant GlaxoSmithKline has entered into a multiyear collaboration with Sirna Therapeutics to develop novel RNAi-based therapeutics for respiratory diseases.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.